- About BE
Company Profile
Biological E Limited, the first private sector biological products company in India and the first pharmaceuticals company in South India.... read more
History
Biological E Limited has a tradition of concern for people and healthcare providers and a dedication to develop the highest quality... read more
Management Philosophy
Late Dr. Vijay Kumar Datla, our Chairman and Managing Director, the force behind Management's thrust, strongly believed... read more
- Business Divisions
Vaccines
BE is the first Indian private company to enter into the vaccine field. Ever since, we have been leaders in vaccinology... read more
Sera & Other Biologics
Biological E Limited is the first private sector Biological Products company in India. Today Biological E. has a formidable... read more
Pharma
From 1977 Biological E Limited has focused on building its pharmaceutical business in India... read more
Public Markets
As the first private sector manufacturer of vaccines and pharmaceutical products in India, Biological E Limited has built up a countrywide distribution... read more
- Product Portfolio
Domestic Vaccines
Biological E. Limited products have been used to protect millions of Indians, through immunization, ever since its inception as a pioneer read more
API
Biological E Limited has been a manufacturer of Active Pharmaceutical Ingredients for many years. The manufacture of these products was initially meant for our own captive needs read more
Domestic Pharma
When Biological E Limited was incorporated as Biological Products Private Limited in 1953, it became the pioneer in the manufacturing of Heparin in India. read more
International Vaccines
BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz.UNICEF, Pan American Health Organisations, other global markets read more
International Pharma
BE supplies several essential and lifesaving Vaccines and Pharmaceuticals to UN Agencies viz.UNICEF, Pan American Health Organisations, other global markets read more
- Business Capabilites
Manufacturing
BE facility at Genome Valley, Hyderabad is one of the largest biotech manufacturing sites in Asia. We have recently invested to introduce two new processing suites... read more
Sales & Distribution
Biological E has a dedicated Vaccine Sales and Marketing team which reaches out more than 8000 Doctors
and has a strong network of CFAs and Vaccine Distributors... read more - Research & Development
Clinical Research
The CRA team consists of young, dynamic, passionate and enthusiastic research professionals. They are capable of meeting... read more
R & D Cycle
Drug discovery is the process by which drugs are discovered, designed and then developed. Despite advances in technology... read more
Partnerships
Biological E.Limited currently has productive partnerships with several well respected and renowned Institutions and Public Health Services... read more
Research Pipeline
BE features a broad range of promising projects in various stages of development. Some of which are highlighted read more
- Media
- Contact us
R & D Cycle
Clinical Research
BE features a broad range of promising projects in various stages of development. Some of which are highlighted below:
VACCINES IN PIPELINE
Liquid Hexavalent Vaccine : In 2013, GlaxoSmithKline and Biological E partnered to develop liquid hexavalent vaccine. The vaccine comprises of diphtheria, tetanus, whole cell pertussis, inactivated polio, haemophilus influenzae type B and hepatitis B.
Pneumococcal Conjugate Vaccine : Biological E is developing a pneumococcal conjugate vaccine comprising of 14 pneumo serotypes.
Typhoid Conjugate Vaccine : Biological E entered into a technology transfer arrangement with Novartis Vaccine Institute for Global Health (NVGH) in 2013.
Paratyphoid Vaccine : In addition to the typhoid conjugate vaccine, Novartis Vaccine Institute for Global Health (NVGH) has licensed paratyphoid vaccine technology to Biological E.
Inactivated Polio Vaccine : Biological E is developing an IPV vaccine and is expected to start Phase 1 trials in India by March 2019
Biological E respects intellectual property owned by others. Products that are protected under valid patents in respective jurisdictions are not offered or supplied for commercial use. Use of products protected by patent are intended solely for the purpose of Research & Development and for generating data for regulatory submissions.
